Detection of circulating gastric carcinoma-associated antigen MG7-Ag in human sera using an established single determinant immuno-polymerase chain reaction technique

作者
Jun Tao Ren,Zheng Chen,Shao Juan Zhou,Xue Yong Zhang,Bo Rong Pan,Dai Ming Fan
出处
期刊:Cancer [Wiley]
卷期号:88 (2): 280-285 被引量:72
标识
DOI:10.1002/(sici)1097-0142(20000115)88:2<280::aid-cncr6>3.0.co;2-7
摘要

BACKGROUND: In 1994, a novel sensitive method termed immuno-polymerase chain reaction (PCR) for the detection of the gastric carcinoma-associated antigen MG7-Ag in the gastric carcinoma cell line KATO III was reported. Compared with the enzyme-linked immunoadsorbent assay, the single determinant immuno-PCR technique could allow for as few as 20 cells to be detected and was found to show an approximately 10,000-fold enhancement in sensitivity of the detection limit. The current study clinically evaluated the significance of serum MG7-Ag detection in gastric carcinoma patients. METHODS: The sera of patients were immobilized on wells and a specific DNA molecule, which could be amplified by PCR, was employed as a marker. The biotinylated monoclonal antibody against gastric carcinoma was added to bind the antigen immobilized on the wells. After the biotinylated antibody was bound to the antigen, free avidin was used to attach a biotinylated monoclonal antibody and biotinylated DNA molecule. The biotinylated DNA complexed with antigen-antibody-avidin was amplified by PCR and the PCR products were analyzed by agarose gel electrophoresis. In the current study this method was used to detect circulating MG7-Ag in the sera of patients with gastric carcinoma and other various malignancies. For comparison, carcinoembryonic antigen, CA 50, CA 19-9, and TAG-72 were quantitated by radioimmunoassay and immunoradiometric assay using the relevant commercial kits in the same sera samples from 86 patients with pathologically confirmed gastric carcinoma and 83 patients with relevant benign diseases of the stomach. In addition, the semiquantitative analysis of PCR products among gastric carcinoma patients with or without metastasis was performed to compare the intensity of DNA band amplification. RESULTS: Using the immuno-PCR assay, positive results were obtained in 164 of 198 patients with gastric carcinoma (82.8%). The rates of positivity in other malignancies were 17.4% for esophageal carcinoma (15 of 86 patients), 44.4% for colonic carcinoma (40 of 90 patients), 0% for liver carcinoma (none of 84 patients), 2.2% for ovarian carcinoma (1 of 45 patients), 0% for uterine carcinoma (none of 27 patients), and 6.1% for lung carcinoma (4 of 66 patients). The positive results obtained from those patients with benign diseases were: 7.7% for peptic ulcer (6 of 78 patients), 5.9% for chronic gastritis (7 of 118 patients), 3.3% for chronic colitis (2 of 60 patients), and 0.8% for healthy blood donors (2 of 236 patients). In addition, the semiquantitative analysis of PCR products showed that the intensity of DNA band amplified from the PCR products of those patients with metastasis was much higher than that of patients without metastasis or those with early stage tumors (1.94 +/- 0.03 vs. 1.28 +/- 0.02). In comparative studies of immuno-PCR and commercial assays for tumor-associated antigens the sensitivity of immuno-PCR was 81.4% and pseudopositivity was lower (8.4% vs. 7.2-12.0% with radioimmunoassay or immunoradiometric assay). CONCLUSIONS: The results of the current study demonstrate that introducing PCR into the indirect determination of tumor-associated antigen in the serum can improve the sensitivity of detection greatly. This novel assay also might be used to monitor the circulating amount of tumor-associated antigen after gastrectomy and provide information regarding recurrence or metastasis, as well as for screening elderly patients who have no indications for endoscopy and those with precancerous conditions. The application of immuno-PCR in the serologic diagnosis of carcinoma has significant advantages including ready application in the clinical setting as well as use as a potential screening tool in mass surveys of high risk populations with gastric carcinoma. (c) 2000 American Cancer Society.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
淡然叫兽完成签到 ,获得积分20
2秒前
2秒前
我是老大的应助被洁净雅彤采纳,获得10
4秒前
王知颖发布了新的文献求助10
5秒前
5秒前
慕青的应助被开心德地采纳,获得10
5秒前
yhe完成签到,获得积分10
5秒前
6秒前
6秒前
大丑橘粑粑柑公主完成签到,获得积分10
7秒前
8秒前
如风随水的应助被风吹麦浪采纳,获得200
9秒前
琪琪发布了新的文献求助10
10秒前
10秒前
10秒前
科研通AI6.3的应助被Susanliu采纳,获得10
11秒前
奈何完成签到 ,获得积分10
12秒前
风吹麦浪的应助被池鱼采纳,获得30
13秒前
wg发布了新的文献求助10
13秒前
FashionBoy的应助被王知颖采纳,获得10
13秒前
科研通AI6.2的应助被liuliu采纳,获得10
13秒前
上官若男的应助被liuliu采纳,获得10
14秒前
大模型的应助被开心德地采纳,获得10
15秒前
完美世界的应助被蟹老板的crab采纳,获得10
15秒前
胡j发布了新的文献求助10
15秒前
17秒前
18秒前
Killua完成签到,获得积分10
20秒前
chunfengfusu的应助被雪山大地采纳,获得10
20秒前
无辜康乃馨完成签到,获得积分10
21秒前
无极微光的应助被时尚的青筠采纳,获得20
22秒前
22秒前
所所的应助被彼岸采纳,获得10
22秒前
Halo完成签到,获得积分10
23秒前
打打的应助被yh采纳,获得10
23秒前
CodeCraft的应助被开心德地采纳,获得10
24秒前
sss完成签到,获得积分10
24秒前
25秒前
25秒前
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188451
求助须知:如何正确求助?哪些是违规求助? 9576286
关于积分的说明 21846376
捐赠科研通 7786514
什么是DOI,文献DOI怎么找? 3435343
关于科研通互助平台的介绍 2559618
邀请新用户注册赠送积分活动 2482322